Company
Traceneuro
Breakthrough Science for People with Neurodegenerative Diseases
Also known as Trace Neuroscience, Trace Neuroscience, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Trace Neuroscience, Inc.
Record updated 28 September 2026
About
Our lead program is an antisense oligonucleotide (ASO), a genetic medicine designed to bind directly to the UNC13A mRNA and ensure proper splicing.